We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Turkcell
TKC
$4.79B
| $67.6K | ﹤0.01% |
13,019
-60,521
| -82% | -$317K |
|
|
AUROW
2827
Aurora Innovation Warrant
AUROW
$370M
| $67.5K | ﹤0.01% |
250,000
+190,708
| +322% | +$55.4K |
|
|
HOOK
2828
DELISTED
HOOKIPA Pharma
HOOK
| $67.5K | ﹤0.01% |
9,476
+7,874
| +492% | +$56K |
|
2829
China Automotive Systems
CAAS
$133M
| $65.7K | ﹤0.01% |
18,504
| – | – |
|
2830
CI&T Inc
CINT
$458M
| $65.5K | ﹤0.01% |
+15,855
| New | +$71.6K |
|
2831
Sight Sciences
SGHT
$412M
| $62.5K | ﹤0.01% |
+11,844
| New | +$55.7K |
|
|
CDTX
2832
DELISTED
Cidara Therapeutics
CDTX
| $61.9K | ﹤0.01% |
+3,362
| New | +$48.3K |
|
2833
Delcath Systems
DCTH
$524M
| $61.8K | ﹤0.01% |
12,959
-8,754
| -40% | -$37.8K |
|
|
AEVA
2834
Aeva Technologies
AEVA
$1.86B
| $59.9K | ﹤0.01% |
15,238
-6,637
| -30% | -$32.1K |
|
2835
Atossa Therapeutics
ATOS
$23.5M
| $59.8K | ﹤0.01% |
2,214
-8,541
| -79% | -$137K |
|
|
UNIT
2836
PUT
Uniti Group
UNIT
$2.32B
| $59K | ﹤0.01% |
10,000
-477,700
| -98% | -$2.73M |
|
2837
Processa Pharmaceuticals
PCSA
$8.61M
| $57K | ﹤0.01% |
964
+927
| +2,505% | +$73.4K |
|
|
SHCR
2838
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $56.2K | ﹤0.01% |
73,194
+4,759
| +7% | +$4.77K |
|
2839
DHI Group
DHX
$173M
| $54.5K | ﹤0.01% |
21,369
-400
| -2% | -$998 |
|
2840
Cumberland Pharmaceuticals
CPIX
$117M
| $54.5K | ﹤0.01% |
32,430
-600
| -2% | -$1.2K |
|
2841
Imperial Petroleum
IMPP
$208M
| $54.4K | ﹤0.01% |
17,385
-57,246
| -77% | -$178K |
|
|
NFGC
2842
New Found Gold
NFGC
$641M
| $52.6K | ﹤0.01% |
+14,223
| New | +$47.4K |
|
|
CTV
2843
DELISTED
Innovid Corp.
CTV
| $52.2K | ﹤0.01% |
20,983
| – | – |
|
|
CMRX
2844
DELISTED
Chimerix, Inc.
CMRX
| $52.1K | ﹤0.01% |
49,111
+37,811
| +335% | +$39.3K |
|
|
DZSI
2845
DELISTED
DZS Inc. Common Stock
DZSI
| $50.6K | ﹤0.01% |
38,297
-49,409
| -56% | -$74.7K |
|
2846
IN8bio
INAB
$9.64M
| $49K | ﹤0.01% |
1,384
-27
| -2% | -$1.02K |
|
2847
CarParts.com
PRTS
$54.7M
| $48.8K | ﹤0.01% |
3,011
-9,068
| -75% | -$227K |
|
2848
HeartCore Enterprises
HTCR
$3.95M
| $47.5K | ﹤0.01% |
2,463
-272
| -10% | -$3.74K |
|
|
NGM
2849
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $44.2K | ﹤0.01% |
27,800
-462,716
| -94% | -$686K |
|
|
ORLA
2850
DELISTED
Orla Mining
ORLA
| $42.4K | ﹤0.01% |
11,189
-73,951
| -87% | -$255K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.